DK213387A - Benzothiazinon-derivater, deres fremstilling og anvendelse - Google Patents

Benzothiazinon-derivater, deres fremstilling og anvendelse

Info

Publication number
DK213387A
DK213387A DK213387A DK213387A DK213387A DK 213387 A DK213387 A DK 213387A DK 213387 A DK213387 A DK 213387A DK 213387 A DK213387 A DK 213387A DK 213387 A DK213387 A DK 213387A
Authority
DK
Denmark
Prior art keywords
benzothiazinon
derivatives
preparation
benzothiazinon derivatives
Prior art date
Application number
DK213387A
Other languages
English (en)
Other versions
DK213387D0 (da
Inventor
Ulrich Lerch
Rainer Henning
Joachim Kaiser
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK213387D0 publication Critical patent/DK213387D0/da
Publication of DK213387A publication Critical patent/DK213387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK213387A 1986-04-28 1987-04-27 Benzothiazinon-derivater, deres fremstilling og anvendelse DK213387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863614363 DE3614363A1 (de) 1986-04-28 1986-04-28 Benzothiazinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung

Publications (2)

Publication Number Publication Date
DK213387D0 DK213387D0 (da) 1987-04-27
DK213387A true DK213387A (da) 1987-10-29

Family

ID=6299713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK213387A DK213387A (da) 1986-04-28 1987-04-27 Benzothiazinon-derivater, deres fremstilling og anvendelse

Country Status (13)

Country Link
EP (1) EP0244723A3 (da)
JP (1) JPS62258371A (da)
KR (1) KR870010028A (da)
AU (1) AU601659B2 (da)
DE (1) DE3614363A1 (da)
DK (1) DK213387A (da)
FI (1) FI871813A (da)
HU (1) HU199814B (da)
IL (1) IL82332A (da)
NO (1) NO871745L (da)
NZ (1) NZ220100A (da)
PT (1) PT84770B (da)
ZA (1) ZA872972B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3724366A1 (de) * 1987-07-23 1989-02-02 Hoechst Ag Benzothiazinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3726759A1 (de) * 1987-08-12 1989-03-09 Hoechst Ag Benzothiazinon-oxide, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung sowie zwischenprodukte zu ihrer herstellung
US5182276A (en) * 1989-06-16 1993-01-26 Santen Pharmaceutical Co., Ltd. Nootropic agent
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
BRPI0404222A (pt) * 2004-06-07 2006-02-07 Fundacao Oswaldo Cruz Compostos derivados da lidocaìna, composições farmacêuticas contendo os mesmos, uso das respectivas composições farmacêuticas no tratamento, prevenção ou inibição de doenças bem como o método de tratamento, prevenção ou inibição de doenças com as ditas composições farmacêuticas
JP6836502B2 (ja) * 2014-05-30 2021-03-03 スプハエラ ファーマ ピーヴィーティー リミテッド 抗結核薬としての新規な化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59148771A (ja) * 1983-02-09 1984-08-25 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
DE3347173A1 (de) * 1983-12-27 1985-07-04 Hoechst Ag, 6230 Frankfurt Neue benzothiazin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0186310A1 (en) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. 1,4-Benzothiazine Derivatives, their production and use
EP0233291B1 (en) * 1985-03-19 1991-03-13 Santen Pharmaceutical Co., Ltd. 2-arylbenzothiazine derivatives
US4786635A (en) * 1985-07-29 1988-11-22 Santen Pharmaceutical Co., Ltd. Novel benzothiazine derivatives

Also Published As

Publication number Publication date
AU601659B2 (en) 1990-09-13
PT84770B (pt) 1989-12-29
AU7199487A (en) 1987-10-29
FI871813A (fi) 1987-10-29
DE3614363A1 (de) 1987-10-29
KR870010028A (ko) 1987-11-30
PT84770A (de) 1987-05-01
JPS62258371A (ja) 1987-11-10
NZ220100A (en) 1990-03-27
ZA872972B (en) 1987-11-25
DK213387D0 (da) 1987-04-27
EP0244723A2 (de) 1987-11-11
NO871745L (no) 1987-10-29
NO871745D0 (no) 1987-04-27
HUT45517A (en) 1988-07-28
HU199814B (en) 1990-03-28
IL82332A (en) 1991-08-16
EP0244723A3 (de) 1988-10-19
IL82332A0 (en) 1987-10-30
FI871813A0 (fi) 1987-04-24

Similar Documents

Publication Publication Date Title
DK462187A (da) Pyridinyl-pyrimidin-derivater, deres fremstilling og anvendelse.
DK595388A (da) Benzopyranderivater, deres fremstilling og anvendelse
DK354687A (da) 7-acyloxy-6-aminoacyloxypolyoxylabdaner, deres fremstilling og anvendelse
DK193088D0 (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK633287D0 (da) Carbamoylimidazo-derivater, deres fremstilling og anvendelse
DK274987D0 (da) Pyrimidin-derivater, deres fremstilling og anvendelse
DK235787D0 (da) Tripeptidderivater, deres fremstilling og anvendelse
DK278188D0 (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
DK213387D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK189488A (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK469389A (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
DK212687D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK607787A (da) 12-halogenerede forskolin-derivater, deres fremstilling og anvendelse
DK610787A (da) Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse
DK223288D0 (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK548586D0 (da) Thienylsulfonylguanidin-derivater, deres fremstilling og anvendelse
DK412188D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK625287D0 (da) 1-aryloxy-3-amino-2-propanoler, deres fremstilling og anvendelse
DK675687A (da) Substituerede n-methylisoxazolidiner, deres fremstilling og anvendelse
DK361388D0 (da) Cephemderivater, deres fremstilling og anvendelse
DK126987A (da) Pyrimidoindoler, deres fremstilling og anvendelse
DK613888A (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK668888D0 (da) Labdan-derivater, deres fremstilling og anvendelse
DK668788D0 (da) Labdanderivater, deres fremstilling og anvendelse
DK727388D0 (da) 2-aminotetrahydroisoquinolinderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
ATS Application withdrawn